Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line

Cancer Letters

Volumn 192, Issue 2, 2003, Pages 205-214

  Moritani, Norifumi H ^a   Kubota, Satoshi ^a   Nishida, Takashi ^a   Kawaki, Harumi ^a   Kondo, Seiji ^a   Sugahara, Toshio ^a   Takigawa, Masaharu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Connective tissue growth factor; Negative regulator; Oral squamous cell carcinoma; Prothymosin alpha

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; PROTHYMOSIN ALPHA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENICITY; CELL CLONE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0037474701     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00718-8     Document Type: Article

References (34)

1. Bradham D.M., Igarashi A., Potter R.L., Grotendorst G.R. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J. Cell Biol. 114:1991;1285-1294.
2. Brigstock D.R. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20:1999;189-206.
3. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Exp. Cell Res. 248:1999;44-57.
4. Takigawa M. Physiological roles of connective tissue growth factor (CTGF/Hcs24): promotion of endochondral ossification, angiogenesis and tissue remodeling. Ikada Y., Shimizu Y. Tissue Engineering for Therapeutic Use 4. 2000;1-13 Elsevier, Amsterdam.
5. Shimo T., Nakanishi T., Nishida T., Asano M., Kanyama M., Kuboki T., Tamatani T., Tezuka K., Takemura M., Matsumura T., Takigawa M. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J. Biochem. (Tokyo). 126:1999;137-145.
6. Xie D., Nakachi K., Wang H., Elashoff R., Koeffler H.P. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61:2001;8917-8923.
7. Wenger C., Ellenrieder V., Alber B., Lacher U., Menke A., Hameister H., Wilda M., Iwamura T., Beger H.G., Adler G., Gress T.M. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene. 18:1999;1073-1080.
8. Kubo M., Kikuchi K., Nashiro K., Kakinuma T., Hayashi N., Nanko H., Tamaki K. Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br. J. Dermatol. 139:1998;192-197.
9. Shakunaga T., Ozaki T., Ohara N., Asaumi K., Doi T., Nishida K., Kawai A., Nakanishi T., Takigawa M., Inoue H. Expression of connective tissue growth factor in cartilaginous tumors. Cancer. 89:2000;1466-1473.
10. Cailleau R., Young R., Olive M., Reeves W.J. Jr. Jr. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53:1974;661-674.
11. Takigawa M., Tajima K., Pan H.O., Enomoto M., Kinoshita A., Suzuki F., Takano Y., Mori Y. Establishment of a clonal human chondrosarcoma cell line with cartilage phenotypes. Cancer Res. 49:1989;3996-4002.
12. Nakanishi T., Nishida T., Shimo T., Kobayashi K., Kubo T., Tamatani T., Tezuka K., Takigawa M. Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology. 141:2000;264-273.
13. Tamatani T., Kobayashi H., Tezuka K., Sakamoto S., Suzuki K., Nakanishi T., Takigawa M., Miyano T. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem. Biophys. Res. Commun. 251:1998;748-752.
14. Nakanishi T., Kimura Y., Tamura T., Ichikawa H., Yamaai Y., Sugimoto T., Takigawa M. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem. Biophys. Res. Commun. 234:1997;206-210.
15. Fan D., Bucana C.D., O'Brian C.A., Zwelling L.A., Seid C., Fidler I.J. Enhancement of murine tumor cell sensitivity to adriamycin by presentation of the drug in phosphatidylcholine-phosphatidylserine liposomes. Cancer Res. 50:1990;3619-3626.
16. Kubota S., Hattori T., Shimo T., Nakanishi T., Takigawa M. Novel intracellular effects of human connective tissue growth factor expressed in Cos-7 cells. FEBS Lett. 474:2000;58-62.
17. Kubota S., Eguchi T., Shimo T., Nishida T., Nakanishi T., Hattori T., Kondo S., Takigawa M. Novel mode of processing and secretion of connective tissue growth factor/ecogenin (CTGF/Hcs24) in chondrocytic HCS-2/8 cells. Bone. 29:2001;155-161.
18. Shimo T., Kubota S., Kondo S., Nakanishi T., Sasaki A., Mese H., Matsumura T., Takigawa M. Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett. 174:2001;57-64.
19. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell. 4:1993;637-645.
20. Nishida T., Nakanishi T., Asano M., Shimo T., Takigawa M. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J. Cell. Physiol. 184:2000;197-206.
21. Gomez-Marquez J., Segade F., Dosil M., Pichel J.G., Bustelo X.R., Freire M. The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. J. Biol. Chem. 264:1989;8451-8454.
22. Lima C.D., Klein M.G., Weinstein I.B., Hendrickson W.A. Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc. Natl. Acad. Sci. USA. 93:1996;5357-5362.
23. Hishikawa K., Oemar B.S., Tanner F.C., Nakaki T., Luscher T.F., Fujii T. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J. Biol. Chem. 274:1999;37461-37466.
24. Hashimoto Y., Shindo-Okada N., Tani M., Nagamachi Y., Takeuchi K., Shiroishi T., Toma H., Yokota J. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells. J. Exp. Med. 187:1998;289-296.
25. Tong X., Xie D., O'Kelly J., Miller C.W., Muller-Tidow C., Koeffler H.P. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J. Biol. Chem. 276:2001;47709-47714.
26. Kleer C.G., Zhang Y., Pan Q., van Golen K.L., Wu Z.F., Livant D., Merajver S.D. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene. 21:2002;3172-3180.
27. Momose F., Araida T., Negishi A., Ichijo H., Shioda S., Sasaki S. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J. Oral. Pathol. Med. 18:1989;391-395.
28. Mori M., Barnard G.F., Staniunas R.J., Jessup J.M., Steele G.D. Jr., Chen L.B. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene. 8:1993;2821-2826.
29. Wu C.G., Habib N.A., Mitry R.R., Reitsma P.H., van Deventer S.J., Chamuleau R.A. Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br. J. Cancer. 76:1997;1199-1204.
30. Sburlati A.R., Manrow R.E., Berger S.L. Prothymosin alpha antisense oligomers inhibit myeloma cell division. Proc. Natl. Acad. Sci. USA. 88:1991;253-257.
31. Rodriguez P., Vinuela J.E., Alvarez-Fernandez L., Gomez-Marquez J. Prothymosin alpha antisense oligonucleotides induce apoptosis in HL-60 cells. Cell Death Differ. 6:1999;3-5.
32. Brenner C., Garrison P., Gilmour J., Peisach D., Ringe D., Petsko G.A., Lowenstein J.M. Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins isolation, cloning and characterization of a low-molecular-mass purine nucleoside- and nucleotide-binding protein. Nat. Struct. Biol. 4:1997;231-238.
33. Brenner C., Bieganowski P., Pace H.C., Huebner K. The histidine triad superfamily of nucleotide-binding proteins. J. Cell Physiol. 181:1999;179-187.
34. Moussad E.E., Brigstock D.R. Connective tissue growth factor: what's in a name? Mol. Genet. Metab. 71:2000;276-292.